Jiye Shi is a Vice President at Eli Lilly and Company, where he oversees Computational Chemistry, Cheminformatics, Structural Biology and Global Sample Management. Jiye started his career in computational design of antibodies in 2001. He is credited as a co-inventor of Bimekizumab, as well as the machine learning algorithm that made the computational design of this medicine possible. His responsibilities later expanded into small molecule drug discovery, leveraging both physics-based and AI/ML approaches. Jiye earned his PhD in Computational Structural Biology at the University of Cambridge and completed his executive MBA training at the University of Rochester. He has co-authored over 200 scientific papers. He is an external advisor to the Department of Statistics at University of Oxford.